Genomic Health nets $54mm in IPO
In its initial public offering, cancer diagnostics company Genomic Health netted $54mm through the sale of about 5mm shares priced at $12 each.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.